30 Day Trial

Stryker Continues to Outpace Competitors with Solid Execution Across Segments

Share:

Stryker reports 3Q19 orthopedic revenue of USD $1,857.6MM, +9.7% vs. 3Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.